Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   BioPharma   /   GTCB - GTC Biotherapeutics - Deel 3

BioPharma« Terug naar discussie overzicht

GTCB - GTC Biotherapeutics - Deel 3

Volgen
1.039 Posts
Pagina: «« 1 ... 42 43 44 45 46 ... 52 »» | Laatste | Omlaag ↓
  6. [verwijderd] 12 september 2006 22:08
    Binck slot

    Laatste 1,21
    Laatste volume 100
    Tijd 19:38
    +/- -0,02 -1,63%
    Volume 187.723

    Bied 00:00
    Biedvolume
    Laat 00:00
    Laatvolume

    Slot 1,23 11/9
    Open 1,24 15:29
    Hoog 1,24 15:29
    Laag 1,18 17:24

    EN BEDANKT VOOR DE SERVICE !
    b.k.
    (AL TWEE DAGEN ONTEVREDEN!)
    over binck dan welteverstaan.

    volgens ticklist
    21:53:13 1,1900 100
    21:53:10 1,1900 100
    21:52:52 1,2000 200
    21:48:55 1,1900 100
    21:48:55 1,1892 100
    21:48:55 1,1900 100
    21:48:55 1,1900 100
    21:48:55 1,1900 200

    is nog nets iets sneller dan bick
  9. [verwijderd] 13 september 2006 06:29
    Re GTCB

    Despite pleas from various persons on this board to try to concentrate on the science and strategy, we can't seem to stay away from the subject of why the pps is so meager. Personally I prefer the science, but feel compelled after reading the litany of these posts to add my two cents.

    Please include IMHO before all my comments.

    The idea the stock is being "manipulated", is well, pardon me, preposterous. This stock has been trading less than 500,000 shares/day, with an average movement of 2cents. That means the total delta/day is less than 10,000$, chump change by street standards, eg the equivalent of 10,000 shares of a 50$ stock going up or down a dollar. You figure out which one takes more effort. What the tape says about GTCB is the volume is low, and the price is drifting down. The diagnosis is no interest on the buy side. Since the science and the prospects are good,

    Why no buyers?? Several reasons first off the share price of less than 1.50$ is simply below the radar screen, undetectable.I was flabergasted to hear Soros owned this stock, but very excited he thought enough of the idea to dip this low.
    GTCB is only slight above Lucifer on Wall Street's list of fallen angels. There are plenty of fund managers who remember when Transgenics was selling for 50$/share in 2000 awaiting FDA approval for Atryn when the company abruptly aborted the trials causing the stock fall faster than Challenger. To the ones who saw guys lose their jobs as well as their money, this stock is purple Koolaid. Some also (I don't agree) feel the company screwed up the EMEA trials and was later given a free pass.

    What will make the stock go up?? News drives small biotechs. A deal with a big pharma would be big (Bristol Myers can you hear me??) A sustaining revinue from a product would be huge and convey to all the worth of the company.

    Until then.......be patient.
    thomson.finance.lycos.com/lycos/iwatc...
  10. [verwijderd] 13 september 2006 07:15
    quote:

    DieGroeneGigant schreef:

    "groen ventje" ?

    GroeneGIGANT !

    RT ? Is ie al op 1.02 ? Dat is eerste stop. Dan technisch herstel en dan dippie naar 0.88 usd. En als het even meezit met emmissies dan zien we toch nog de 0.75 usd. Lekker laag !

    Inmiddels wel 14% gezakt vanaf laatste top.

    print.chartnet.nl/Show.cgi?Img=FF298E...
    Waar is die " Gap '" Gigant???
    B.K.
    Beurskabouter.
  13. [verwijderd] 13 september 2006 08:22
    quote:

    Beurs-kneus schreef:

    [quote=DieGroeneGigant]
    "groen ventje" ?

    GroeneGIGANT !

    RT ? Is ie al op 1.02 ? Dat is eerste stop. Dan technisch herstel en dan dippie naar 0.88 usd. En als het even meezit met emmissies dan zien we toch nog de 0.75 usd. Lekker laag !

    Inmiddels wel 14% gezakt vanaf laatste top.

    print.chartnet.nl/Show.cgi?Img=FF298E...
    [/quote]

    Waar is die " Gap '" Gigant???
    B.K.
    Beurskabouter.
    Wat willen jullie hiermee bereiken? Houd het s.v.p. zakelijk of open voor jullie zelf een afzonderlijk draadje waar jullie je "vete" afzonderlijk uitvechten.
  20. ludwig mack 13 september 2006 11:12
    quote:

    SkySpam1 schreef:

    Re GTCB

    Despite pleas from various persons on this board to try to concentrate on the science and strategy, we can't seem to stay away from the subject of why the pps is so meager. Personally I prefer the science, but feel compelled after reading the litany of these posts to add my two cents.

    Please include IMHO before all my comments.

    The idea the stock is being "manipulated", is well, pardon me, preposterous. This stock has been trading less than 500,000 shares/day, with an average movement of 2cents. That means the total delta/day is less than 10,000$, chump change by street standards, eg the equivalent of 10,000 shares of a 50$ stock going up or down a dollar. You figure out which one takes more effort. What the tape says about GTCB is the volume is low, and the price is drifting down. The diagnosis is no interest on the buy side. Since the science and the prospects are good,

    Why no buyers?? Several reasons first off the share price of less than 1.50$ is simply below the radar screen, undetectable.I was flabergasted to hear Soros owned this stock, but very excited he thought enough of the idea to dip this low.
    GTCB is only slight above Lucifer on Wall Street's list of fallen angels. There are plenty of fund managers who remember when Transgenics was selling for 50$/share in 2000 awaiting FDA approval for Atryn when the company abruptly aborted the trials causing the stock fall faster than Challenger. To the ones who saw guys lose their jobs as well as their money, this stock is purple Koolaid. Some also (I don't agree) feel the company screwed up the EMEA trials and was later given a free pass.

    What will make the stock go up?? News drives small biotechs. A deal with a big pharma would be big (Bristol Myers can you hear me??) A sustaining revinue from a product would be huge and convey to all the worth of the company.

    Until then.......be patient.
    thomson.finance.lycos.com/lycos/iwatc...

    leuk betoog met leuke beeldspraak, maar in het begin van betoog een denkfout: de reden achter de lage koers is volgens mij overname of gewoon opbouwen van een belang. dat er niet veel kopers zijn ligt ook ook de lage koers die kunstmatig is en alleen bij goedkeuring de enorme vraag op dat moment niet kon tegen gehouden. veder is omzet in aantallen niet echt laag te noemen; m.a.w. er komt toch heel wat los per dag dat ze gestaag binnenharken.
    ben benieuwd !
1.039 Posts
Pagina: «« 1 ... 42 43 44 45 46 ... 52 »» | Laatste |Omhoog ↑

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
HEIJMANS KON 38,000 +4,65 +13,94%
Brunel 10,160 +0,70 +7,40%
TomTom 4,614 +0,14 +3,22%
JDE PEET'S 17,400 +0,48 +2,84%
BESI 119,700 +2,70 +2,31%
ALLFUNDS GROUP 4,954 +0,10 +1,98%
ASCX 1.362,07 +26,24 +1,96%
PROSUS 45,975 +0,89 +1,96%
Flow Traders 26,140 +0,50 +1,95%
Air France-KLM 8,506 +0,14 +1,65%
IMCD 149,050 +2,15 +1,46%
JUST EAT TAKEAWAY 12,425 +0,18 +1,43%
ABN AMRO BANK N.V. 17,800 +0,25 +1,40%
Philips Koninklijke 24,310 +0,31 +1,29%
Corbion 22,820 +0,28 +1,24%
Galapagos 25,640 +0,30 +1,18%
EXOR NV 94,100 +1,10 +1,18%
Nedap N.V. 60,600 +0,60 +1,00%
ACOMO 18,400 +0,18 +0,99%
Kendrion 10,360 +0,10 +0,97%
Akzo Nobel 58,060 +0,56 +0,97%
BAM 4,914 +0,04 +0,90%
Heineken 78,240 +0,68 +0,88%
INPOST 17,460 +0,15 +0,87%
ArcelorMittal 27,050 +0,23 +0,86%
Basic-Fit 22,440 +0,18 +0,81%
Wereldhave 15,380 +0,12 +0,79%
SBM Offshore 20,940 +0,16 +0,77%
ING 16,564 +0,12 +0,75%
KPN 3,507 +0,02 +0,69%
NSI 22,450 +0,15 +0,67%
SIGNIFY NV 21,420 +0,14 +0,66%
AALBERTS NV 36,300 +0,22 +0,61%
ASMI 569,800 +3,40 +0,60%
ForFarmers 3,800 +0,02 +0,53%
UNILEVER PLC 53,300 +0,28 +0,53%
Eurocommercial Properties 24,050 +0,10 +0,42%
DSM FIRMENICH AG 101,100 +0,40 +0,40%
OCI 11,060 +0,04 +0,36%
Ahold Delhaize 33,630 +0,12 +0,36%
AMX 859,41 +2,09 +0,24%
Van Lanschot Kempen NV 48,400 +0,10 +0,21%
RENEWI 10,260 +0,02 +0,20%
ASML 710,100 +0,20 +0,03%
Avantium 1,826 0,00 0,00%
AZERION 1,640 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
EBUSCO HOLDING 0,595 -0,03 -5,03%
THEON INTERNAT 17,060 -0,36 -2,07%
CM.COM 6,350 -0,12 -1,85%
Arcadis 49,480 -0,92 -1,83%
NN Group 46,410 -0,86 -1,82%
RELX 47,260 -0,82 -1,71%
Wolters Kluwer 172,600 -2,90 -1,65%
Alfen N.V. 12,025 -0,18 -1,43%
VASTNED 27,900 -0,40 -1,41%
Vopak 39,160 -0,54 -1,36%
SHELL PLC 32,155 -0,44 -1,33%
Fugro 14,310 -0,18 -1,24%
WDP 20,960 -0,26 -1,23%
ADYEN NV 1.787,000 -17,80 -0,99%
PostNL 1,060 -0,01 -0,93%
AMG Critical Materials N.V. 16,260 -0,15 -0,91%
Fagron 19,240 -0,14 -0,72%
RANDSTAD NV 38,120 -0,27 -0,70%
ASR Nederland 48,400 -0,26 -0,53%
Aegon 5,832 -0,03 -0,51%
B&S Group SA 4,285 -0,02 -0,46%
UMG 28,020 -0,13 -0,46%
NX FILTRATION 3,260 -0,02 -0,46%
FASTNED 19,900 -0,08 -0,40%
CTP 16,280 -0,06 -0,37%
Pharming 0,873 0,00 -0,29%
Aperam 29,360 -0,08 -0,27%
Sligro 10,560 -0,02 -0,19%
Sif Holding 11,120 -0,02 -0,18%
TKH 37,420 -0,04 -0,11%
AEX 937,58 -1,00 -0,11%
Accsys 0,495 0,00 -0,10%
vlag naam koers verschil relatief verschil
AEX 937,58 -1,00 -0,11%
AEX GR 3.684,23 -3,92 -0,11%
DE40 22.287,56 -27,09 -0,12%
FTSE 100 8.659,37 -3,60 -0,04%
Europe50^ 5.474,85 +13,82 +0,25%
US30^ 43.424,20 0,00 0,00%
Nasd100^ 21.616,30 0,00 0,00%
US500^ 6.014,32 0,00 0,00%
Japan225^ 38.152,90 0,00 0,00%
VD-NEW 18,45 -1,93 -9,46%
#/^ Index indications calculated real time, zie disclaimer